Follow the Krsnaa Diagnostics Limited share price and the full directors' dealings record of the company, a listed equity based in India. Shares are quoted on IN IN, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Krsnaa Diagnostics Limited has recorded 13 insider filings. Market capitalisation: €17.5bn. The latest transaction was disclosed on 30 December 2024 (Purchase). Among the most active insiders: Phi Capital Trust - Phi Capital Growth Fund - 1. The full history is accessible without an account.
13
Insider Decl.
0
Thresholds
€3m
13 ops.
Buy Volume
·
0 ops.
Sell Volume
10Σ signal
Buys €3m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 7,809 of 26,211 companies
61.5
score / 100
Value
54
Quality
69
FCF yld-4.5%
Earn yld6.0%
EV/EBITDA8.7x
ROE11%
Gross mgn69%
Net mgn13%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.